Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cureus ; 16(3): e55343, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38559513

RESUMEN

Introduction Combination antifungal regimens are frequently employed in the treatment of invasive fungal infections in patients who are immunocompromised, particularly for cancer and transplant patients. Terbinafine is a potential agent of interest for combination regimens. Methods We reviewed data over a six-year period examining patient outcomes in terms of both mortality and distribution of pathogens. The total number of patients in our study was 64. The use of terbinafine versus no terbinafine in combination therapy was assessed. Of the 64 patients analyzed, only 14 received terbinafine. Mortality was calculated for both groups, and demographics were analyzed by descriptive statistics. Results There was no statistical difference in mortality outcomes in either group. The addition of terbinafine was well tolerated and did not appear to result in any undue toxicity concerns. Discussion We wish to draw greater attention to this potential agent within our armamentarium for invasive fungal infections. To our knowledge, the total number of patients in our study, while small, represents the largest reported cohort in the literature to date. Sensitivities are crucial to be obtained for fungal pathogens as this likely undermined the utility of terbinafine in our study with larger than expected numbers of multidrug-resistant Fusarium. With limited patient numbers, a multicenter trial would be beneficial to further examine terbinafine in combination regimens.

2.
BMC Infect Dis ; 24(1): 296, 2024 Mar 06.
Artículo en Inglés | MEDLINE | ID: mdl-38448809

RESUMEN

Chronic disseminated candidiasis (CDC) is a severe but rarely seen fungal infection presenting in patients with hematologic malignancies after a prolonged duration of neutropenia. A high index of suspicion is required to diagnose CDC as standard culture workup is often negative. While tissue biopsy is the gold standard of diagnosis, it is frequently avoided in patients with profound cytopenias and increased bleeding risks. A presumptive diagnosis can be made in patients with recent neutropenia, persistent fevers unresponsive to antibiotics, imaging findings of hypoechoic, non-rim enhancing target-like lesions in the spleen and liver, and mycologic evidence. Here, we describe the case of an 18-year-old woman with relapsed B-cell acute lymphoblastic leukemia treated with re-induction chemotherapy who subsequently developed CDC with multi-organ involvement. The diagnosis was made based on clinical and radiologic features with positive tissue culture from a skin nodule and hepatic lesion. The patient was treated for a total course of 11 months with anti-fungal therapy, most notably amphotericin B and micafungin, and splenectomy. After initial diagnosis, the patient was monitored with monthly CT abdomen imaging that showed disease control after 5 months of anti-fungal therapy and splenectomy. The diagnosis, treatment, and common challenges of CDC are outlined here to assist with better understanding, diagnosis, and treatment of this rare condition.


Asunto(s)
Candidiasis , Neoplasias Hematológicas , Leucemia Mieloide Aguda , Neutropenia , Femenino , Humanos , Adolescente , Candidiasis/diagnóstico , Candidiasis/tratamiento farmacológico
3.
Cureus ; 15(4): e38256, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37252590

RESUMEN

Introduction Coccidian protozoa and microsporidian fungi are opportunistic pathogens increasingly implicated in infections in immunosuppressed individuals. These parasites typically infect the intestinal epithelium, resulting in secretory diarrhea and malabsorption. The disease burden and timeline are both greater and longer among immunosuppressed patients. Therapeutic options for immunocompromised individuals are limited. As a result, we wanted to better characterize the disease course and treatment efficacy of these parasitic gastrointestinal infections. Methods We performed a single-center, retrospective MedMined (BD Healthsight Analytics, Birmingham, AL, USA) chart review of patients between January 2012 and June 2022 diagnosed with coccidian or microsporidian infections. Relevant data were collected from Cerner's PowerChart (Oracle Cerner, Austin, TX, USA). Descriptive analysis was performed with IBM SPSS Statistics (IBM Corp., Armonk, NY, USA), and Microsoft Excel (Microsoft, Redmond, WA, USA) was used to generate graphs and tables. Results In these 10 years, there were 17 patients with Cryptosporidium infections, four with Cyclospora infections, and no positive cultures for Cystoisospora belli or microsporidian infections. In both infections, the majority of patients experienced diarrhea, fatigue, and nausea, with vomiting, abdominal pain, appetite loss, weight loss, and fever occurring to a lesser degree. Nitazoxanide was the most common treatment for Cryptosporidium, while trimethoprim-sulfamethoxazole or ciprofloxacin were the treatments of choice for Cyclospora. Of the Cryptosporidium infections, three received combination therapy with azithromycin, immunoreconstitution, or IV immunoglobulins. Among the four Cyclospora-infected patients, one received combination therapy of ciprofloxacin and trimethoprim-sulfamethoxazole. Treatment lasted around two weeks, and 88% of Cryptosporidium patients and 75% of Cyclospora patients had a resolution of symptoms. Conclusion The most detected coccidian infection was Cryptosporidium, followed by Cyclospora, with the lack of Cystoisospora or microsporidian infections likely due to diagnostic limitations and prevalence. Cryptosporidium and Cyclospora likely caused their associated symptoms in most cases, with other possible etiologies, including graft-versus-host disease, medications, and feeding tubes. The small number of patients receiving combination therapy prohibited a comparison with monotherapy. In our patient population, though, there was a clinical response to treatment despite immunosuppression. While promising, additional randomized control experiments are required to fully understand the efficacy of parasitic treatments.

4.
Transplant Cell Ther ; 29(4): 277.e1-277.e9, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-35970303

RESUMEN

CD19 targeted chimeric antigen receptor-modified T cell therapy (CAR-T) leads to B cell aplasia and low serum immunoglobulin levels. Long-lived CD19-negative plasma cells may persist through the therapy and generate antibodies. There is a paucity of data describing how CAR-T impacts the persistence of antibodies against vaccine-related antigens and the degree to which CAR-T recipients may respond to vaccines. We characterized the effect of CAR-T on pneumococcal immunoglobulin G (IgG) titers and determine whether pneumococcal conjugate vaccine (PCV13) administered after CAR-T develops long-term humoral protection against pneumococcus. A retrospective chart review was performed to identify CAR-T recipients who had serum pneumococcal IgG titers drawn before (baseline) or at days +90, +180, +270, +360, or +540 after CAR-T. We then determined whether they received PCV13 vaccination at these timepoints. IgG concentration ≥1.3 µg/mL was considered protective for that serotype, and patients with ≥6/11 tested vaccine-specific serotypes meeting this threshold were deemed to have humoral protection against pneumococcus. Absolute pneumococcal IgG titers and the proportion of patients with humoral protection, stratified by serotype, and vaccination status were compared by paired nonparametric t-tests. Absolute counts for lymphocyte, CD4 T-cell, and CD19 cell and total IgG level, along with the rate of invasive pneumococcal infections, were measured at these timepoints. A total of 148 CAR-T recipients with pneumococcal IgG titers measured for at least one of the defined time points were identified. At baseline, 25% (19/76) patients with evaluable pneumococcal IgG titers met the definition of humoral protection. Among 44 patients with paired pneumococcal IgG titers at baseline and day+90, absolute IgG titers of all serotypes decreased (geometric mean = 0.41 and 0.32 µg/mL, respectively; P < .001). Thirteen patients were vaccinated following the titer blood draw at day+90 and had paired pneumococcal IgG titers at day+90 and day180. Absolute IgG titers of all vaccine specific serotypes in these vaccinated patients decreased from day+90 to day+180 (geometric mean = 0.36 and 0.29 µg/mL, respectively; P = .03). The proportion of patients meeting the criteria of humoral protection remained the same at day+180 despite vaccination at day+90. The results were similar among 8 patients vaccinated at day+180, as well as 7 patients consecutively vaccinated at day+90 and day+180 with corresponding pneumococcal IgG titers. When all vaccine-specific pneumococcal IgG titers were pooled together by timepoint regardless of vaccination status, the proportion of patients with humoral protection decreased until day+540. Some patients developed humoral protection after vaccination at day+360, maintained seroprotective IgG titers from baseline, or developed protection after receiving intravenous immunoglobulin treatment secondary to recurrent infections. Our study demonstrated that few large B cell lymphoma patients had humoral protection against pneumococcus at baseline, and existing IgG titers decreased after CAR-T. PCV13 vaccination at day+90 or day+180 after CAR-T did not increase humoral protection against pneumococcus. Only at day+540 was there evidence of humoral protection against pneumococcus in a modest proportion of patients. Clinical trials are needed to determine the optimal timing of vaccination, before or after CAR-T, to develop protective immunity against Streptococcus pneumoniae infections.


Asunto(s)
Infecciones Neumocócicas , Receptores Quiméricos de Antígenos , Humanos , Vacunas Conjugadas , Estudios Retrospectivos , Inmunoterapia Adoptiva , Anticuerpos Antibacterianos , Infecciones Neumocócicas/prevención & control , Infecciones Neumocócicas/tratamiento farmacológico , Streptococcus pneumoniae , Vacunas Neumococicas/uso terapéutico , Inmunoglobulina G
6.
Polymers (Basel) ; 15(23)2023 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-38231968

RESUMEN

The aim of this study is to investigate the impact of mechanical recycling on the physical and mechanical properties of recycled polyamide 6 (PA6) and polyamide 66 (PA66) in relation to their microstructures. Both PA6 and PA66 raw materials were reprocessed six times, and the changes in their properties were investigated as a function of recycling number. Until the sixth round of recycling, slight changes in the mechanical properties were detected, except for the percentage of elongation. For the physical properties, the change in both flexural strength and Young's modulus followed a decreasing trend, while the trend in terms of elongation showed an increase. Microscopic analysis was performed on virgin and recycled specimens, showing that imperfections in the crystalline regions of polyamide 6 increased as the number of cycles increased.

7.
Blood Adv ; 6(24): 6109-6119, 2022 12 27.
Artículo en Inglés | MEDLINE | ID: mdl-35939783

RESUMEN

Idecabtagene vicleucel (ide-cel) was FDA-approved in March 2021 for the treatment of relapsed/refractory multiple myeloma after 4 lines of therapy. On the KarMMa trial, grade ≥ 3 cytopenias and infections were common. We sought to characterize cytopenias and infections within 100 days after ide-cel in the standard-of-care (SOC) setting. This multi-center retrospective study included 52 patients who received SOC ide-cel; 47 reached day-90 follow-up. Data were censored at day 100. Grade ≥ 3 cytopenia was present among 65% of patients at day 30 and 40% of patients at day 90. Granulocyte colony stimulating factor (G-CSF) was administered to 88%, packed red blood cell transfusions to 63%, platelet transfusions to 42%, thrombopoietin (TPO) agonists to 21%, intravenous immunoglobulin to 13%, and CD34+ stem cell boosts to 8%. At day 100, 19% and 13% of patients had ongoing use of TPO agonists and G-CSF, respectively. Infections occurred in 54% of patients and were grade ≥ 3 in 23%. Earlier infections in the first 30 days were typically bacterial (68%) and severe (50%). Later infections between days 31 and 100 were 50% bacterial and 42% viral; only 13% were grade ≥ 3. On univariate analysis, high pre-CAR-T marrow myeloma burden (≥ 50%), circulating plasma cells at pre-lymphodepletion (LD), and grade ≥ 3 anemia at pre-LD were associated with grade ≥ 3 cytopenia at both days 30 and 90. Longer time from last bridging treatment to LD was the only significant risk factor for infection.


Asunto(s)
Anemia , Mieloma Múltiple , Receptores Quiméricos de Antígenos , Trombocitopenia , Humanos , Mieloma Múltiple/terapia , Estudios Retrospectivos , Nivel de Atención , Factor Estimulante de Colonias de Granulocitos
8.
IDCases ; 29: e01525, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35712054

RESUMEN

Bacillus cereus (B. cereus) is a known cause of a food poisoning in the general population. However, it can cause life-threatening sepsis and shock in severely immunocompromised patients with hematologic malignancies, which frequently lead to central nervous system (CNS) infections associated with high mortality and morbidity. In this case report, we describe a patient with a newly diagnosed acute myeloid leukemia that underwent induction chemotherapy and developed B. cereus infection that was associated with septic shock and brain abscesses. Definitive diagnosis of multiple brain abscesses was not manifested with routine microbiological investigation but required the use of 16S ribosomal (rRNA) gene polymerase chain reaction (PCR) sequencing of the resected brain lesion. The patient was eventually treated with 8-week course of intravenous vancomycin and high-dose ciprofloxacin which led to a full recovery. This report highlights the significant risk posed by B. cereus infection in neutropenic patients, the use of 16S rRNA PCR sequencing test for definitive diagnosis and use of combination therapy for successful treatment of B. Cereus CNS infection.

9.
Polymers (Basel) ; 13(11)2021 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-34073740

RESUMEN

The present study proposes a reparation method for designing and optimizing a rubber to rubber and rubber to textile reinforcement. The present application is the conveyor belt used in the transport industry. The tensile behavior of the repaired specimens was studied using experimental results. A bidirectional linear analysis allows us to predict the effect of geometric parameters on the stress concentration zone of the repaired belt under hygro-thermo mechanical loading and its consequence on the integrity of the structure. A tensile test was carried out in order to investigate the behavior of a repaired specimen made with a rubber cover patch and an inner composite patch. Two stacking sequences of an inner composite patch and the material properties are considered in the parametric study in order to reduce the stress concentration in the parent belt. The correlation between the theoretical and experimental results allows us to define a strength tool to understand the load transfer from rubber to a textile rubber patch.

10.
Polymers (Basel) ; 14(1)2021 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-35012040

RESUMEN

This work presents the influences of glass fiber content on the mechanical and physical characteristics of polybutylene terephthalate (PBT) reinforced with glass fibers (GF). For the mechanical characterization of the composites depending on the GF reinforcement rate, tensile tests are carried out. The results show that increasing the GF content in the polymer matrix leads to an increase in the stiffness of the composite but also to an increase in its brittleness. Scanning Electron Microscope analysis is performed, highlighting the multi-scale dependency on types of damage and macroscopic behavior of the composites. Furthermore, flammability tests were performed. They permit certifying the flame retardancy capacity of the electrical composite part. Additionally, fluidity tests are carried out to identify the flow behavior of the melted composite during the polymer injection process. Finally, the cracking resistance is assessed by riveting tests performed on the considered electrical parts produced from composites with different GF reinforcement. The riveting test stems directly from the manufacturing process. Therefore, its results accurately reflect the fragility of the material used.

11.
Infect Chemother ; 51(1): 45-53, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30941937

RESUMEN

BACKGROUND: Staphylococcus lugdunensis is a coagulase-negative staphylococcus (CoNS) that is a part of the normal human skin flora. Even though it belongs to CoNS family, it can cause severe and destructive infections in a similar fashion to Staphylococcus aureus. Skin and soft tissue infections (SSTI), bacteremia and endocarditis are amongst the most common clinical presentations. Diagnosis and clinical presentation of infections caused by S. lugdunensis in cancer patients is limited. MATERIALS AND METHODS: We performed a retrospective chart review of 24 patients who had cultures positive for S. lugdunensis. Out of 24 patients, 14 patients were diagnosed with a true infection and 10 other patients were considered to be colonized with this pathogen. We analyzed clinical manifestation, treatment and response to therapy. RESULTS: SSTI was the most common presentation in our study patients. All patients diagnosed with SSTI had a prior surgery or an invasive procedure at the affected site. Five urinary tract infections (UTIs), one catheter-associated bloodstream infection, and a deep pelvic abscess were other reported infections in our study. We observed that S. lugdunensis remains susceptible to a variety of antibiotics, with all isolates susceptible to vancomycin and linezolid and most remain susceptible to fluoroquinolone and trimethoprim/ sulfamethoxazole. All 14 patients received antibiotics and improved. CONCLUSION: In our case series, SSTI was common and diagnosed in 50% of the patients with clinically significant isolates for S. lugdunensis. This is consistent with prior studies indicating that S. lugdunensis is a significant pathogen in SSTIs. UTI was the second most common infection type in our patient population.

13.
Mol Cell Biochem ; 362(1-2): 103-14, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22038629

RESUMEN

Hypertension is sexually dimorphic and modified by removal of endogenous sex steroids. This study tested the hypothesis that endogenous gonadal hormones exert differential effects on protein expression in the kidney and mesentery of SHR. At ~5 weeks of age male and female SHR underwent sham operation, orchidectomy, or ovariectomy (OVX). At 20-23 weeks of age, mean arterial pressure (MAP) was measured in conscious rats. The mesenteric arterial tree and kidneys were collected, processed for Western blots, and probed for Cu Zn superoxide dismutase (SOD1), soluble epoxide hydrolase (sEH), and Alpha 2A adrenergic receptor (A2AR) expression. MAP was unaffected by ovariectomy (Sham 164 ± 4: Ovariecttomy 159 ± 3 mm Hg). MAP was reduced by orchidectomy (Sham 189 ± 5:Orchidectomy 167 ± 2 mm Hg). In mesenteric artery, SOD1 expression was greater in male versus female SHR. Orchidectomy increased while ovariectomy decreased SOD1 expression. The kidney exhibited a different pattern of response. SOD1 expression was reduced in male compared to female SHR but gonadectomy had no effect. sEH expression was not significantly different among the groups in mesenteric artery. In kidney, sEH expression was greater in males compared to females. Ovariectomy but not orchidectomy increased sEH expression. A2AR expression was greater in female than male SHR in mesentery artery and kidney. Gonadectomy had no effect in either tissue. We conclude that sexually dimorphic hypertension is associated with regionally specific changes in expression of three key proteins involved in blood pressure control. These data suggest that broad spectrum inhibition or stimulation of these systems may not be the best approach for hypertension treatment. Instead regionally targeted manipulation of these systems should be investigated.


Asunto(s)
Presión Sanguínea/fisiología , Hormonas Gonadales/metabolismo , Hipertensión/fisiopatología , Animales , Epóxido Hidrolasas/biosíntesis , Femenino , Humanos , Hipertensión/genética , Hipertensión/metabolismo , Riñón/metabolismo , Masculino , Arterias Mesentéricas/metabolismo , Orquiectomía , Ovariectomía , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas SHR , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 2/biosíntesis , Caracteres Sexuales , Superóxido Dismutasa/biosíntesis , Superóxido Dismutasa-1
14.
Reprod Sci ; 17(9): 809-22, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20601541

RESUMEN

This study tested the hypothesis that reciprocal communication occurs between macrophages and cultured human endometrial stromal cells and that this communication may contribute to the pathology of endometriosis. An endometrial stromal cell line (telomerase-immortalized human endometrial stromal cell [T-HESC]) was treated with macrophage-conditioned medium (CM) +/- estradiol + progesterone. Macrophages were treated without or with T-HESC CM. DNA microarray identified 716 differentially expressed genes in T-HESCs in response to factors secreted by macrophages. Upregulated genes in T-HESC included interleukin 8 (IL-8)/chemokine (C-X-C motif) ligand 8 (CXCL8), matrix metalloproteinase 3 (MMP3), phospholamban, cysteine-rich angiogenic inducer 61 (CYR61), connective tissue growth factor (CTGF), tenascin C, and nicotinamide N-methyltransferase (NNMT), whereas integrin alpha-6 was downregulated. In contrast, 15 named genes were differentially expressed in macrophages in response to factors secreted by endometrial stromal cells. The data document reciprocal communication between macrophages and endometrial stromal cells and suggest that interaction with macrophages stimulates the expression of genes in endometrial stromal cells that may support the establishment of endometriosis.


Asunto(s)
Endometriosis/metabolismo , Endometrio/metabolismo , Macrófagos/metabolismo , Comunicación Paracrina , Células del Estroma/metabolismo , Medios de Cultivo Condicionados/metabolismo , Endometriosis/genética , Endometriosis/patología , Endometrio/efectos de los fármacos , Endometrio/patología , Estradiol/farmacología , Femenino , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica , Humanos , Macrófagos/efectos de los fármacos , Acetato de Medroxiprogesterona/farmacología , Análisis de Secuencia por Matrices de Oligonucleótidos , Comunicación Paracrina/efectos de los fármacos , Comunicación Paracrina/genética , Prolactina/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células del Estroma/efectos de los fármacos , Células del Estroma/patología , Células U937
15.
Reprod Sci ; 17(2): 125-36, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19843877

RESUMEN

Immune system cells and cells of the endometrium have long been proposed to interact in both physiological and pathological processes. The current study was undertaken to examine communication between cultured monocytes and endometrial stromal cells and also to assess responses of endometrial stromal cells for treatment with estradiol (E) in the absence and presence of medroxyprogesterone acetate (P). A telomerase-immortalized human endometrial stromal cell (T-HESC) line and the U937 monocyte cell line were used. Telomerase-immortalized human endometrial stromal cells were treated with E +/- P +/- monocyte conditioned medium; U937 were treated +/- T-HESC conditioned medium. Gene expression in response to treatment was examined by DNA microarray. Bidirectional communication, as demonstrated by changes in gene expression, clearly occurred between U937 monocytes and T-HESC.


Asunto(s)
Comunicación Celular/fisiología , Endometriosis/patología , Endometrio/citología , Monocitos/citología , Células del Estroma/citología , Comunicación Celular/efectos de los fármacos , Línea Celular Transformada , Medios de Cultivo Condicionados/farmacología , Endometriosis/fisiopatología , Estradiol/farmacología , Femenino , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos , Prolactina/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Telomerasa/genética , Células U937
16.
Fertil Steril ; 88(6): 1505-33, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17462640

RESUMEN

OBJECTIVE: To use DNA microarrays to identify differentially expressed genes in eutopic endometrium compared with ectopic endometrium. DESIGN: Prospective, cross-sectional, observational study. SETTING: University Medical Center and Research Laboratory. PATIENT(S): Eleven women with endometriosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Differential gene expression. RESULT(S): Seven hundred seventeen of the 53,000 probes on the whole human DNA microarrays were changed by twofold or greater in ectopic versus eutopic endometrium. Families of genes that were expressed differentially include genes that code for proteins associated with the immune system and inflammatory pathways, cell adhesion, cell-cell junctions, the extracellular matrix and its remodeling, cytoskeletal proteins, and signal transduction pathway components, among others. CONCLUSION(S): The altered immune environment may allow survival of endometriotic cells that enter the abdominal cavity. Alterations of cell adhesion-associated genes may contribute to the adhesive and invasive properties of ectopic endometrium, and changes in signal transduction pathways support a change in the communication among cells of the endometrial explant compared with eutopic endometrium. These families of differentially expressed genes provide multiple opportunities for the development and testing of new hypotheses regarding endometriosis.


Asunto(s)
Endometriosis/genética , Endometrio/metabolismo , Perfilación de la Expresión Génica , Genoma Humano , Análisis de Secuencia por Matrices de Oligonucleótidos , Enfermedades Peritoneales/genética , Adulto , Estudios Transversales , ADN/análisis , Endometriosis/patología , Femenino , Humanos , Persona de Mediana Edad , Enfermedades Peritoneales/patología , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...